Answer:
Gene splicing is a post-transcriptional modification in which a single gene can code for multiple proteins. Gene Splicing is done in eukaryotes, prior to mRNA translation, by the differential inclusion or exclusion of regions of pre-mRNA. Gene splicing is an important source of protein diversity.
Answer:
1 - R
2 - r
3 - R
4 - RR
5 - Rr
6 - r
7 - Rr
8 - rr
Explanation: hope this helps
Answer:
D. Complex I, Ubiquinone, Complex III, Cytochrome C, Complex IV, Oxygen.
Explanation:
Answer: <em>The Bottleneck Effect</em>
Explanation:
A Bottleneck effect is the sharp reduction of numbers of a population through environmental effects or human activity. It causes a loss of the genetic pool and its variety; genetic variation lowers and increases with time as random mutations occur.
Answer:
Phase III
Explanation:
The given condition fall in the trial phase (Phase III) of cinical study which aims to:
- Determine drug's effectiveness (primary goal)
- Determine long-term drug safety
- Confirm findings
In Phase III, randomised, double-blind, placebo-controlled, parallel group study is majorly to evaluate the efficacy and safety of placebo in episodic migraine prevention in children (6 to < 12 years of age) and adolescents (12 to < 18 years of age).
The trial consists of four phases: screening; double-blind therapy period for 24 weeks in which placebo or Erenumab is given to subject as dose 1, dose 2 or dose 3 (based on the participant's body weight) once a month via subcutaneous injection; optional dose level blinded extension phase (40 weeks) which involves subjects recieve dose1, 2 and 3 of placebo, and at last it follows a safety follow-up phase for 12 weeks (after 16 weeks of the last dose of investigational drug).
Hence, the clinical phase is phase III.
